Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 15002134094 |
| E-mail: | marketing@targetmol.cn |
| QQ: | 2881954871 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Leramistat | C20H21ClN2O3S | 1642602-54-7 | Details |
| Ilaprazole sodium hydrate | C19H21N4NaO3S | 2322264-11-7 | Details |
| MuRF1-IN-2 | C23H22N2O7 | 937891-74-2 | Details |
| Erythronic acid | C4H8O5 | 13752-84-6 | Details |
| (R)-Azasetron besylate | C17H20ClN3O3.C6H6O3S | 2025360-91-0 | Details |
| A-77636 | C20H27NO3 | 778546-51-3 | Details |
| OPC-163493 | C14H8F3N5S | 1644467-84-4 | Details |
| Dihydro-5-azacytidine acetate | 2470972-18-8 | Details |
| SRI 6409-94 | C24H29NO3 | 127697-58-9 | Details |
| EGFR-IN-85 | C26H30N8O2 | 1956378-29-2 | Details |
| U-89843A | C16H24ClN5 | 157013-85-9 | Details |
| PDE7-IN-3 | C18H21ClN2O4 | 908570-13-8 | Details |
| M62812 free base | C13H11N3OS | 613262-61-6 | Details |
| Anti-amyloid agent-1 | C21H17F3N2O3 | 1396778-73-6 | Details |
| NS2B/NS3-IN-3 hydrochloride | C19H21N3O2.ClH | 2832876-91-0 | Details |
| SLC26A3-IN-3 | C20H17IO5 | 2369983-43-5 | Details |
| Z-LLF-CHO | C29H39N3O5 | 133429-58-0 | Details |
| HPK1-IN-35 | C30H32N8O3S | 2935903-77-6 | Details |
| Antileishmanial agent-14 | 1638956-72-5 | Details |
| Xilmenolone | C26H37N3O2 | 2368807-26-3 | Details |
| Neuraminidase-IN-13 | 2222067-23-2 | Details |
| SHP2-IN-13 | C16H21N7O | 2951854-02-5 | Details |
| SJ1461 | C21H18ClN7OS2 | 2924546-70-1 | Details |
| TH-Z835 | C30H38N6O | 2766209-50-9 | Details |
| LTB4 antagonist 2 | C26H23NO6 | 2929239-85-8 | Details |
| Anticancer agent 164 | C21H23F3N8O2S2 | 2235393-30-1 | Details |
| SHP2-IN-5 | C12H8O6 | 54755-93-0 | Details |
| RET-IN-22 | C29H31F3N6O4 | 2918281-79-3 | Details |
| LTB4 antagonist 3 | C29H27NO6 | 2929239-87-0 | Details |
| CK2-IN-9 | C23H29N9O | 1461658-58-1 | Details |
| CS640 | C21H31N7O | 2388506-83-8 | Details |
| Thalidomide-NH-C10-NH2 hydrochloride | C23H32N4O4.ClH | 2460022-53-9 | Details |
| RDR 02308 | C19H15N3O3 | 4155-82-2 | Details |
| GBT1118 | C19H20N2O4 | 1628799-51-8 | Details |
| 84-B10 | C25H22F3NO5 | 698346-43-9 | Details |
| Dihydromyristicin | C11H14O3 | 52811-28-6 | Details |
| Ledipasvir hydrochloride | C49H55ClF2N8O6 | 2128695-48-5 | Details |
| PU-48 | C14H12N2O3S | 335394-78-0 | Details |
| BODIPY FL thalidomide | C37H43BF2N6O7 | 2740620-18-0 | Details |
| Antitubercular agent-36 | 2883173-82-6 | Details |
| NLRP3-IN-17 | C21H22N4O2S | 2254432-75-0 | Details |
| MC-VA-PAB-Exatecan | C50H54FN7O11 | 2680543-57-9 | Details |
| Asp-Asp-Asp-Asp-Asp-Asp | C24H32N6O19 | 145224-96-0 | Details |
| Brazilein | C16H12O5 | 600-76-0 | Details |
| CYP11A1-IN-1 | C27H34N2O5 | 2744168-51-0 | Details |
| Antimalarial agent 19 | 2897630-89-4 | Details |
| E235 | C28H25FN4OS | 891894-69-2 | Details |
| Amine-PEG3-Lys(PEG3-N3)-PEG3-N3 | C30H58N10O12 | 2244602-35-3 | Details |
| Ac-Exatecan | C26H24FN3O5 | 2922852-48-8 | Details |
| LL-37, Human TFA | C???H???N??O??.C?HF?O? | Details |
| Pomalidomide-5-C10-NH2 hydrochloride | C23H32N4O4.ClH | 2863635-00-9 | Details |
| Lepzacitinib | C18H21N5O3 | 2321488-47-3 | Details |
| JNJ-1013 | C46H55N9O7S | 2597343-08-1 | Details |
| S07-1066 | C16H11Cl2FO2 | 876625-29-5 | Details |
| IDO1-IN-21 | 2892432-98-1 | Details |
| Cholesterol nervonate | C51H90O2 | 60758-73-8 | Details |
| Eledoisin Related Peptide 2TFA | C34H58N8O6S | Details |
| (R)-VX-11e | C24H20Cl2FN5O2 | 1680187-43-2 | Details |
| Aβ/tau aggregation-IN-3 | C23H22N4O3 | 1210750-32-5 | Details |
| TFLLR-NH2 2TFA(197794-83-5(free base)) | C31H53N9O6 | Details |
| Demethylcantharidate disodium | C8H11NaO5 | 129-67-9 | Details |
| Smurf1-IN-1 | C24H29ClN6O2 | 1824708-03-3 | Details |
| Yhhu6669 | C29H28ClFN6O3 | 2569526-80-1 | Details |
| BRD4 Inhibitor-28 | C23H21N3O3 | 2468960-80-5 | Details |
| NLRP3-IN-21 | C20H13Cl2F3N6O2S | 2956791-61-8 | Details |
| TWIK-1/TREK-1-IN-2 | C20H29F3N2O2 | 1440532-32-0 | Details |
| AMX12006 | C26H22F3N3O3 | 2639775-01-0 | Details |
| BChE/HDAC6-IN-1 | C34H43N5O5 | 2925457-27-6 | Details |
| AJH-836 | C22H38O5 | 388621-67-8 | Details |
| Nrf2 activator-7 | 2456295-39-7 | Details |
| EGFR-IN-82 | C32H41BrN9O2P | 2568086-81-5 | Details |
| SIRT5 inhibitor 7 | C28H32ClN7O3S | 2951090-00-7 | Details |
| BTM-3528 | C24H19F4N3O2S2 | 2054998-45-5 | Details |
| Anticancer agent 110 | C18H13FN6OS | 887349-03-3 | Details |
| ZINC475239213 | C21H15N5O2 | 2871002-89-8 | Details |
| SIKs-IN-1 | C27H31F2N7O | 2927557-06-8 | Details |
| SIRT5 inhibitor 6 | C21H28N6O4S | 2834736-82-0 | Details |
| EP12 | C26H22FN3O2 | 2882916-73-4 | Details |
| MAO-B-IN-23 | C19H18BrNO | 2107978-22-1 | Details |
| HIV-1 inhibitor-57 | C25H24FN5O3S | 2745197-24-2 | Details |
| Keap1-Nrf2-IN-15 | 2456295-45-5 | Details |
| J-1048 | C23H17FN6S2 | 2374772-60-6 | Details |
| YIAD-0205 | C26H16Br2ClN3 | 2446054-34-6 | Details |
| MMP13-IN-4 | C21H17BrN4O5 | 514855-02-8 | Details |
| α-Synuclein inhibitor 9 | C27H24O4 | 1510825-03-2 | Details |
| SARS-CoV-2 nsp14-IN-3 | C17H17N3O3S | 2920574-16-7 | Details |
| DNA gyrase B-IN-3 | C14H9Cl2N3O4S | 2412834-56-9 | Details |
| TWIK-1/TREK-1-IN-1 | C21H24F3NO3 | 1440532-30-8 | Details |
| CDK/HDAC-IN-3 | C24H18Cl2N6O3 | 2944087-54-9 | Details |
| Dim16 | C29H38IN5 | 2743448-32-8 | Details |
| Aurora Kinases-IN-4 | C26H28N8O | 2877011-84-0 | Details |
| BC-05 | C21H29BN2O9 | 2260717-73-3 | Details |
| LSD1-UM-109 | C29H27FN6 | 2252446-26-5 | Details |
| IL-1β-IN-2 | 2242896-76-8 | Details |
| MY-673 | C18H14N2O4 | 2944459-96-3 | Details |
| HDAC-IN-63 | C25H26Cl2N6O3 | 2920046-95-1 | Details |
| hnNOS-IN-2 | C18H23F2N3 | 2700326-00-5 | Details |
| MmpL3-IN-3 | C26H33ClN2Si | 1639438-67-7 | Details |
| Chitin synthase inhibitor 14 | C25H26ClN5O5 | 2922114-19-8 | Details |
| Product Total： Product Page： | ||||
| 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 | ||||